To strengthen and promote the Swiss biotech industry, the Swiss Biotech Association collaborates with numerous partners and life science clusters globally under the brand Swiss …
The antiviral medicine remdesivir from Gilead Sciences failed to speed the improvement of patients in China with Covid-19 or prevent them from dying.
For weeks, the world has been eagerly awaiting clinical trial results for one experimental drug, remdesivir, to treat Covid-19.
With no time to make treatments from scratch, researchers search for existing compounds that deflect harm
A team of scientists worked around the clock to evaluate 14 antibody tests. A few worked as advertised. Most did not.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 21, 2020.
In the race to develop a vaccine to end the COVID-19 pandemic, governments, charities and Big Pharma firms are sinking billions of dollars into bets with extraordinarily low odds of success.